Login / Signup

Improved Synthesis of Caged Glutamate and Caging Each Functional Group.

Charitha GurugeYannick P OuedraogoRichard L ComitzJingxuan MaAttila LosonczyNasri Nesnas
Published in: ACS chemical neuroscience (2018)
Glutamate is an excitatory neurotransmitter that controls numerous pathways in the brain. Neuroscientists make use of photoremovable protecting groups, also known as cages, to release glutamate with precise spatial and temporal control. Various cage designs have been developed and among the most effective has been the nitroindolinyl caging of glutamate. We, hereby, report an improved synthesis of one of the current leading molecules of caged glutamate, 4-carboxymethoxy-5,7-dinitroindolinyl glutamate (CDNI-Glu), which possesses efficiencies with the highest reported quantum yield of at least 0.5. We present the shortest route, to date, for the synthesis of CDNI-Glu in 4 steps, with a total reaction time of 40 h and an overall yield of 20%. We also caged glutamate at the other two functional groups, thereby, introducing two new cage designs: α-CDNI-Glu and N-CDNI-Glu. We included a study of their photocleavage properties using UV-vis, NMR, as well as a physiology experiment of a two-photon uncaging of CDNI-Glu in acute hippocampal brain slices. The newly introduced cage designs may have the potential to minimize the interference that CDNI-Glu has with the GABAA receptor. We are broadly disseminating this to enable neuroscientists to use these photoactivatable tools.
Keyphrases
  • magnetic resonance
  • resting state
  • molecular dynamics
  • intensive care unit
  • liver failure
  • risk assessment
  • mass spectrometry
  • respiratory failure
  • brain injury
  • drug induced
  • single molecule
  • quantum dots